Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific association for the study of the liver (APASL): an update Shiv Kumar SarinAshok ChoudhuryAPASL ACLF Research Consortium (AARC) for APASL ACLF working Party. Guidelines Open access 06 June 2019 Pages: 353 - 390
New treatment-induced adverse effects we need to learn as modern hepatologists Yoshiyuki Ueno Invited Commentary 23 April 2019 Pages: 391 - 394
The first Chinese guidelines on the Management of Ascites and its Related Complications in Cirrhosis: a great goal for a great country P. Angeli Commentary 16 July 2019 Pages: 395 - 398
Association of acute-on-chronic liver failure with vascular liver diseases Akash ShuklaAbhinav Jain Point-of-View 07 June 2019 Pages: 399 - 402
Hepatology through the crystal ball Roger Williams Review Article Open access 04 July 2019 Pages: 403 - 406
Prediction and clinical implications of HBV reactivation in lymphoma patients with resolved HBV infection: focus on anti-HBs and anti-HBc antibody titers Tsutomu NishidaTokuhiro MatsubaraMasami Inada Review Article 09 July 2019 Pages: 407 - 415
Current status and perspectives for computer-aided ultrasonic diagnosis of liver lesions using deep learning technology Naoshi NishidaMakoto YamakawaMasatoshi Kudo Review Article 21 February 2019 Pages: 416 - 421
Pegylated-interferon consolidation treatment versus nucleos(t)ide analogue consolidation treatment in non-cirrhotic hepatitis B patients with hepatitis B e antigen seroconversion: an open-label pilot trial Ying ZhouRong YanHong Wang Original Article 06 June 2019 Pages: 422 - 430
Long-term virological and serologic responses of chronic hepatitis B virus infection to tenofovir disoproxil fumarate-containing regimens in patients with HIV and hepatitis B coinfection Yu-Shan HuangHsin-Yun SunChien-Ching Hung Original Article 08 June 2019 Pages: 431 - 439
CCN2–MAPK–Id-1 loop feedback amplification is involved in maintaining stemness in oxaliplatin-resistant hepatocellular carcinoma Xia LiaoYang BuQingan Jia Original Article Open access 27 June 2019 Pages: 440 - 453
Alteration of splicing factors’ expression during liver disease progression: impact on hepatocellular carcinoma outcome Hualin WangBouchra LekbabyPatrick Soussan Original Article 28 May 2019 Pages: 454 - 467
Nonselective beta-blockers and development of portal vein thrombosis in liver cirrhosis: a systematic review and meta-analysis Xiangbo XuXiaozhong GuoXingshun Qi Original Article 07 June 2019 Pages: 468 - 481
Bacteroides in colonic mucosa-associated microbiota affects the development of minimal hepatic encephalopathy in patients with cirrhosis Masafumi HaraguchiSatoshi MiumaKazuhiko Nakao Original Article 09 July 2019 Pages: 482 - 489
Prognostic subclass of intrahepatic cholangiocarcinoma by integrative molecular–clinical analysis and potential targeted approach Keun Soo AhnDaniel O’BrienKoo Jeong Kang Original Article 18 June 2019 Pages: 490 - 500
SHG/TPEF-based image technology improves liver fibrosis assessment of minimally sized needle biopsies Bingqiong WangYameng SunHong You Original Article Open access 11 June 2019 Pages: 501 - 509
Biliary features in liver histology of children with autoimmune liver disease Angelo Di GiorgioA. D’AddaL. D’Antiga Original Article 08 May 2019 Pages: 510 - 518